Panacos Pharmaceuticals
Latest round
- Series C
Last raised
- May 2004
Total raised
- $23M
Investors
- 11
About Panacos Pharmaceuticals
Panacos Pharmaceuticals is a biotechnology company focused on developing antiviral therapies.Panacos Pharmaceuticals, founded in 1999 in Watertown, US, specializes in antiviral drug development. The company underwent a strategic pivot in its operations to enhance its focus on therapeutic solutions. M. Pappas & Associates and Ampersand Capital Partners.Panacos Pharmaceuticals specializes in developing and commercializing antiviral therapies aimed at addressing significant health challenges. Their flagship product is designed to target viral infections, effectively catering to healthcare providers and research institutions globally.The company's revenue model is based on direct sales and partnerships, primarily engaging in B2B agreements for the acquisition of antiviral therapies. Clients typically enter into contractual arrangements, which may involve subscription-based pricing or one-time purchases, facilitating scalable solutions to meet their needs. Upcoming therapies designed for viral treatment are in the pipeline, with anticipated launch dates set for the next two years. The company is targeting expansion into emerging markets in Asia and Europe by the end of 2025, aiming to establish a broader presence in the global biotechnology sector.
Who invested in Panacos Pharmaceuticals
11 investors across 2 rounds
See all investors in Panacos Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Panacos Pharmaceuticals
Who invested in Panacos Pharmaceuticals?
Panacos Pharmaceuticals has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Panacos Pharmaceuticals raised?
Panacos Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Panacos Pharmaceuticals last raise money?
Panacos Pharmaceuticals's most recent round on record is a Series C, in May 2004.
What does Panacos Pharmaceuticals do?
Panacos Pharmaceuticals is a biotechnology company focused on developing antiviral therapies.
Where is Panacos Pharmaceuticals headquartered?
Panacos Pharmaceuticals is headquartered in Watertown, US.
Which VCs invest in companies like Panacos Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Panacos Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Panacos Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.